الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 110 |  |  |
| | | from | 110 | | |
Abstract
MMR and BCG vaccines seem to be a highly promising effective and safe treatment modality for warts. Because of their low cost, high level of tolerability, widespread effect involving both the treated and untreated warts, and low recurrence rate, we propose that MMR and BCG may be considered a first-line therapy for multiple warts and a second-line therapy for warts recalcitrant to standard therapies. In conclusion, intralesional immunotherapy with BCG and MMR vaccines seem to be a promising effective and safe treatment modality for viral warts. The wide spread use of BCG and MMR vaccines in the treatment of different types of warts, single or multiple, recalcitrant or non-recalcitrant, may provide an important addition to the challenging field of wart therapy.